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Abstract: The Gammacoronavirus infectious bronchitis virus (IBV) is a highly contagious economically
important respiratory pathogen of domestic fowl. Reverse genetics allows for the molecular study
of pathogenic determinants to enable rational vaccine design. The recombinant IBV (rIBV) Beau-R,
a molecular clone of the apathogenic Beaudette strain, has previously been investigated as a vaccine
platform. To determine tissues in which Beau-R could effectively deliver antigenic genes, an in vivo
study in chickens, the natural host, was used to compare the pattern of viral dissemination of Beau-R
to the pathogenic strain M41-CK. Replication of Beau-R was found to be restricted to soft tissue within
the beak, whereas M41-CK was detected in beak tissue, trachea and eyelid up to seven days post
infection. In vitro assays further identified that, unlike M41-CK, Beau-R could not replicate at 41 ◦C,
the core body temperature of a chicken, but is able to replicate a 37 ◦C, a temperature relatable to the
very upper respiratory tract. Using a panel of rIBVs with defined mutations in the structural and
accessory genes, viral replication at permissive and non-permissive temperatures was investigated,
identifying that the Beau-R replicase gene was a determinant of temperature sensitivity and that
sub-genomic mRNA synthesis had been affected. The identification of temperature sensitive allelic
lesions within the Beau-R replicase gene opens up the possibility of using this method of attenuation
in other IBV strains for future vaccine development as well as a method to investigate the functions
of the IBV replicase proteins.
Keywords: coronavirus; IBV; temperature sensitivity; replicase; RNA synthesis
1. Introduction
Infectious bronchitis virus (IBV) is a Gammacoronavirus and is the aetiological agent of the
acute highly contagious and economically important respiratory disease, infectious bronchitis,
which affects domestic fowl. Other coronaviruses that cause respiratory disease are the zoonotic
betacoronaviruses that can cause severe respiratory disease in humans including severe acute respiratory
syndrome coronavirus (SARS-CoV) that emerged in 2003 [1,2], Middle East respiratory syndrome
coronavirus (MERS-CoV) that emerged in 2012 [3] and SARS-CoV-2 that recently emerged in 2019 [4].
The alphacoronaviruses HCoV-229E, HCoV-NL63 as well as the betacoronaviruses HCoV-OC43
and HCoV-HKU1 also cause respiratory disease in humans but typically with less severe clinical
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symptoms [5]. The Alphacoronavirus porcine respiratory coronavirus (PRCV) is reported to inflict
respiratory disease in pigs [6].
IBV is known to be predominantly spread through droplet and aerosol transmission [7]. There are
several co-circulating strains of IBV, in terms of genotypes and serotypes, which inflict varying levels of
disease, with vaccination against one often eliciting poor protective immune responses to another [8].
Infection with M41, a Massachusetts serotype and one that is of particular relevance to the global
poultry industry [8], results in classical IB symptoms including snicking, rales, watery eyes, nasal
discharge, lethargy, reduced weight gain in broilers and reduced egg laying as well as egg quality in
layers. In addition, nephropathogenic strains of IBV have been identified in which viral replication is
not confined to the respiratory tract with replication occurring in the kidneys. Nephropathogenic IBV
strains, such as QX and B1648, are able to disseminate, initially from the respiratory tract, through the
bird and infect the enteric tract, oviducts and kidneys, often resulting in severe renal disease [9–11].
Vaccination against IBV is commonly practiced using live attenuated vaccines administered to
young chicks en masse through sprays or via drinking water, with older layer birds typically boosted
with inactivated vaccines [8]. All current live attenuated vaccines are produced through serial passage
of a virulent field isolate through embryonated hens’ eggs, typically 80 to 100 times [12,13]. A fine
balance between attenuation and the retention of immunogenicity must be achieved and although this
process of vaccine development is well established, the molecular mechanisms are poorly understood.
Recent research has indicated only a few consensus level mutations are acquired over the passaging
process presenting a short possible route back to virulence [14]. There is therefore a drive to understand
pathogenic determinants present in the IBV genome, to enable the generation of rationally attenuated
IBV vaccines.
The advent of reverse genetics systems has opened the potential for developing rationally
attenuated IBV viruses as vaccines [15–18]. The recombinant IBV (rIBV) Beau-R, a molecular clone of
the attenuated Beaudette strain Beau-CK [19], has been investigated as a vaccine backbone. Several
studies have demonstrated that Beau-R expressing an S gene from a pathogenic isolate, can induce a
protective immune response against the pathogenic wild type IBV strain from which the “donor” S
sequence was derived [15,16,20]. The vaccine strain H52 lacking accessory genes 3 and 5 can induce
a protective immune response against homologous challenge [17]. A recombinant H120 expressing
the S1 subunit from a QX like strain induced a better protection rate to homologous challenge in
comparison to vaccination with H120 [18]. Whilst the research is promising, the ultimate question of
how these vaccine virus backbones are attenuated is still unanswered. The H52 and H120 backbones
were generated through serial passage in embryonated hens’ eggs [12] and the complete passage
history of the Beaudette strain, first isolated in 1937, is unknown although reports suggest this strain
has been passaged upward of 200 times [15]. The Beaudette strain is a particular enigma as it is thought
that the virus is so attenuated it can no longer initiate effective replication in vivo nor induce any
protective immune response [15,21].
In this study the in vivo dissemination of the attenuated rIBV Beau-R was compared to the
pathogenic strain M41-CK. Beau-R replication was found to be highly restricted with infectious virus
recovered from the beak but not from the trachea. Replication of IBV in tracheal epithelial cells
has long been associated with clinical signs and pathology associated with IB in chickens. In vitro
assays identified that Beau-R replication is temperature sensitive and cannot be maintained at 41 ◦C,
the core body temperature of a chicken. Utilising a panel of rIBV, the replicase gene was identified as a
determining factor in the restriction of the replication of Beau-R at the non-permissive temperature.
The inability of Beau-R to replicate at 41 ◦C likely contributes to the attenuated in vivo phenotype
associated with IBV Beaudette. Whilst this finding has implications for the use of Beau-R as a backbone
for the development of rationally designed recombinant vaccines, it supplements previous research
that the coronavirus replicase gene is a determinant of pathogenicity [22–28]. It also highlights the
possibility, with greater understanding, that temperature sensitivity could be used as a method for
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the design of rationally attenuated vaccine viruses as currently seen with viral pathogens including
influenza virus and rhinoviruses [29–32].
2. Materials and Methods
2.1. Cells and Viruses
Primary chicken kidney (CK) cells were prepared from kidneys extracted from two three-week-old
specific pathogen free (SPF) Rhode Island Red (RIR) chickens [33]. DF1 cells are a continuous cell line
derived from chicken embryo fibroblasts [34]. All cell cultures were produced by the Central Services
Unit at The Pirbright Institute and maintained, prior to infection, at 37 ◦C and 5% CO2.
All viruses were propagated in embryonated RIR hens’ eggs, supplied by the National Avian
Facility (NARF), The Roslin Institute. Allantoic fluid was clarified by low speed centrifugation and
either titrated in CK cells in triplicate or in ex vivo tracheal organ cultures (TOCs) as described
previously [15]. Titres are displayed as either the number of plaque forming units (PFU) per ml or
as the dose required to causes 50% ciliostasis (CD50). The rIBVs Beau-R [19], BeauR-M41(S) [35] and
BeauR-M41-Struct [23] have been described previously, as have the laboratory strains M41-CK [35],
Beau-CK [19] and serially egg passaged viruses M41-CK EP106 A, A1, C and D [14]. The H120 vaccine
strain was a gift from Professor R. Jones at the University of Liverpool and nephropathogenic strain
D388 [36], a gift from Professor J.J de Wit at The GD Animal Health, Netherlands.
2.2. In Vivo Characterisation
All animal experimental protocols were carried out in strict accordance with the UK Home Office
guidelines and under licence granted for experiments involving regulated procedures on animals
protected under the UK Animals (Scientific Procedures) Act 1986. The experiment was performed in
The Pirbright Institute Home Office licenced (X24684464) experimental animal house facilities and
were approved (AR000772, 4 August 2016) by the animal welfare and ethical review committee under
the terms of reference HO-ERP-01-1.
SPF RIR chickens were housed in raised floor pens in separate positive pressure high-efficiency
particulate air (HEPA) filtered rooms in groups of 24 birds. Chickens were inoculated with 100 µL
containing 104 PFU of rIBV Beau-R or IBV M41-CK or 100 µL Phosphate Buffered Saline (PBS) for mock
infection via the intra-nasal and intra-ocular route at seven days of age. Clinical signs, including rales
and snicking were observed from one to seven days post infection (dpi) as previously described [20].
One, four and six dpi, six randomly selected birds per group were culled by cervical dislocation. A
variety of tissues were harvested with sections stored in either PBS or RNALater (Ambion, Thermo
Fisher Scientific, Waltham, MA, USA). On day seven, post infection, all remaining birds were euthanized
by cervical dislocation. Ciliary activity was assessed in trachea extracted 4 and 6 dpi as previously
described [37,38].
2.3. Virus Re-Isolation in Embryonated Hens’ Eggs
Infectious virus was re-isolated from harvested tissues in ten-day old SPF Valo embryonated
hens’ eggs. Tissue was homogenised using a tissue lyser II (Qiagen, Hilden, Germany), in 500 µl PBS
containing 10 U/mL penicillin, 10 µg/mL streptomycin and 50 U/mL nystatin followed by clarification
by low speed centrifugation. Each egg was inoculated with 100 µL clarified tissue derived supernatant
and incubated for 24 h at 37 ◦C. Embryos were culled using a schedule 1 method and the allantoic
fluid harvested, which was screened for viral presence by RT-PCR utilising primers that target the 3′
UTR as described previously [23].
2.4. In Vitro Growth Kinetic Experiments
DF1 or CK cells, seeded in six or twelve well plates, were infected with 104 PFU, 105 PFU, or 1.5
log10CD50 (MOI ~0.001–~0.01) rIBV or IBV, and incubated for 1 h at 37 ◦C, 5% CO2 or 41 ◦C, 5% CO2.
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Inoculum was removed, and cells were washed twice with PBSa to remove unbound virus. Per well,
3 mL BES (N,N-Bis(2-hydroxyethyl)-2aminoethanesulphonic acid) medium [39] was added, and cells
were incubated at either 37 ◦C, 5% CO2 or 41 ◦C, 5% CO2. Supernatant containing viral progeny,
one well per time point, was harvested at defined intervals post infection (pi) and titrated in triplicate
in CK cells. Each experiment was performed three times.
2.5. Analysis of sgmRNA Synthesis by Quantitative Real-Time PCR (qRT-PCR)
CK cells seeded in 6 well plates were inoculated with 106 PFU (multiplicity of infection (MOI)
~0.01) of Beau-R or M41-CK and incubated at either 37 ◦C or 41 ◦C. After 24 hpi, supernatant was
harvested and assessed for infectious progeny by titration in CK cells. Cell lysate was also harvested,
and RNA was extracted using RNeasy columns (QIAgen), following the manufacturer’s instructions,
including on column DNAse treatment. Reverse transcription of 1 µg total RNA was performed
using the Superscript III Reverse Transcriptase kit (Invitrogen, Waltham, MA, USA) according to
the manufacturer’s protocol using random primers (Promega, Madison, WI, USA). The viral RNA
load was quantified using quantitative real-time PCR (qRT-PCR) using primers targeting the N
sub-genomic mRNA (sgmRNA). Quantitative RT-PCR was performed using TaqMan Universal Master
Mix II, no UNG (Life Technologies, Waltham, MA, USA) including 125 nM final probe and 500 nM
final primers. The primer and probe sequences were taken from Maier et al. (2013) [40] and are as
follows: forward primer located in the leader sequence, 5′-CTAGCCTTGCGCTAGATTTTTAACT-3′;
reverse primer located in the N gene 5′-GAGAGGTACACGCGGGACAA-3′; and N sgmRNA probe
sequence, 5′-FAM-ACAAAGCAGGACAAGCA-MGB-NFQ-3′. Standard curves were performed to
allow quantitation of IBV RNA copy numbers based on cDNA levels using plasmids containing the
sequence amplified by the set of primers listed above. The resulting Ct results were used to calculate
the log of relative RNA copies (Log10) using the linear equation from the standard curve.
2.6. Temperature Swap Assays
CK cells seeded in six well plates were inoculated with 105 PFU (MOI ~0.01) of rIBV or IBV.
Infected cells were incubated at either 37 ◦C or 41 ◦C for 1 h (1st incubation), after which the inoculum
was removed, and cells washed with PBSa to remove unbound virus. Per well, 3 mL BES media was
added, and cells were incubated for a further 23 h at either 37 ◦C or 41 ◦C (2nd incubation). Supernatant
was harvested from three wells for each experimental condition, and each was titrated in triplicate
in CK cells to determine the quantity of infectious progeny virus. Each experiment was performed
three times.
2.7. Co-Infection Assay
CK cells seeded in six well plates were inoculated in triplicate with 105 PFU (MOI ~0.01) of
M41-CK, Beau-R, co-infected with 105 PFU Beau-R and 105 PFU M41-CK or mock infected with BES
media. Cells were incubated at 37 ◦C, 5% CO2 or 41 ◦C, 5% CO2 for 1 h, after which the inoculum
was removed, and cells washed once with PBSa to remove any unbound virions. Per well, 3 mL
BES media was added, and cells were incubated at either 37 ◦C or 41 ◦C until extensive CPE was
observed in the 37 ◦C Beau-R and M41-CK control samples, typically 48 to 72 hpi. The supernatants
were harvested and passaged a further four times in CK cells, using the same incubation conditions as
the original passage. Passage 5 supernatant was screened for viral presence using RT-PCR utilising
primers targeting the 3′ UTR, described previously [23].
2.8. Analysis of Protein Expression by Western Blot
CK cells were seeded in six well plates and inoculated with 106 PFU M41-CK, Beau-R or BES
media for mock infection and incubated at either 37 ◦C or 41 ◦C. At 8, 11 and 24 hpi cell lysates
were harvested using radioimmunoprecipitation assay (RIPA) lysis buffer (Thermo Fisher Scientific,
Waltham, MA, USA) with Protein Inhibitor Cocktail added (Thermo Fisher Scientific). Cell lysates were
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resolved using sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and were
then transferred to a nitrocellulose membrane. Non-specific binding sites were blocked using a 5%
milk solution in PBS-tween (PBS-T) for 1 h at room temperature. The blots were probed with anti-IBV
primary antibody (dilution 1:1000, Abcam, ab31671) and β-actin (dilution 1:2000, Abcam, ab8227).
Bound antibodies were detected with Donkey anti-Chicken (dilution 1:15,000, Licor, 926-68075) and
Goat anti-Rabbit (dilution 1:15,000, Abcam, ab150077). Visualisation of membrane was carried out
using the LICOR Odyssey CLx Imaging System.
2.9. Statistics
Each figure details the statistical tests used to analyse the data set presented. Graphpad Prism,
version 7.0 was used for all statistical analysis. Prior to each statistical test the normality of each data
set was assessed.
3. Results
3.1. Replication of rIBV Beau-R is Restricted In Vivo
In order to establish the in vivo sites of Beau-R replication, groups of seven-day old SPF RIR
chickens were inoculated with either M41-CK, Beau-R or mock infected with PBS. Clinical signs
including snicking (Figure 1a) and rales (Figure 1b) were assessed from 1–7 dpi. No IBV induced
clinical signs were observed in the mock group or the birds infected with Beau-R. In contrast, chickens
infected with M41-CK displayed snicking and rales from 2 dpi, with the rate of snicking peaking
at 5 dpi and the percentage of birds with rales peaking at 6 dpi. Tracheas were harvested from six
randomly selected birds per group, 4 and 6 dpi and the ciliary activities assessed. Ciliary activities
of tracheal epithelial cells are used as a marker to determine whether a pathogenic isolate of IBV is
present [41]. The mean ciliary activities were comparable between the mock and Beau-R infected birds,
99% and 95% respectively, 4 dpi and 95% and 96%, respectively, 6 dpi. In contrast, M41-CK infected
birds exhibited ciliary activities of 1% and 0.4% (p < 0.0001) on days 4 and 6 dpi, respectively (Figure 1c).
The absence of clinical signs together with the retention of ciliary activities confirms previous the
reports that Beau-R has an attenuated phenotype in vivo [15,16,42].
To determine the sites of viral replication for Beau-R and M41, eyelids, beak and tracheas were
harvested from six randomly selected chickens per group at 1, 4, 6 and 7 dpi. For the purpose of
this study, the beak refers to all soft tissue within the beak cavity including the nasal turbinates
and nasal-associated lymphoid tissue (NALT), and eyelids includes both the upper and lower lid.
To determine whether infectious progeny virions were being produced in the selected tissues,
embryonated hens’ eggs were inoculated with tissue-derived supernatants and the resulting allantoic
fluid analysed by RT-PCR (Table 1) for the presence of IBV RNA using a primer set specific for the 3′
UTR [23]. Due to a 184 bp deletion within the 3′ UTR of the M41-CK genome, the RT-PCR products
generated from this primer set can be easily distinguished, on size difference, between M41-CK and
Beau-R derived RNA [23]. As expected, no infectious Beau-R was isolated from tracheal samples on
any sampling day, compared to at least 50% of tracheal samples testing positive for the presence of
M41-CK on each sampling day post-infection. M41-CK was detected in eyelid tissue harvested from
all birds 4 and 6 dpi and in four of six birds and five of six birds, 1 and 7 dpi respectively. Beau-R
was not detected in the harvested eyelid tissue except for one bird at day 7 dpi. All beak tissue,
however, tested positive for the presence of Beau-R at 1 dpi, which was comparable to M41-CK at
this time point, but the detection of Beau-R dropped to ≤50% at 4 and 7 dpi with none detected at 6
dpi. These results indicate that Beau-R replication is confined to tissue within the beak, and largely
restricted to early infection.
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Table 1. The number of birds positive for virus isolation in each group.
Group Dpi Beak Eyelid Trachea
Mock 1 0/6 0/6 0/6
Beau-R 1 6/6 0/6 0/6
M41-CK 1 6/6 4/6 0/6
Mock 4 0/6 0/6 0/6
Beau-R 4 2/6 0/6 0/6
M41-CK 4 6/6 6/6 5/6
Mock 6 0/6 0/6 0/6
Beau-R 6 0/6 0/6 1/6
M41-CK 6 0/6 6/6 5/6
Mock 7 0/6 0/6 0/6
Beau-R 7 2/4 1/4 0/4
M41-CK 7 2/4 * 5/6 2/5 *
Notes: * Samples from the trachea of one bird and beak tissue from two birds were damaged during processing and
therefore were unable to be included in the dataset. Beak refers to all soft tissue within the beak cavity, including
nasal turbinates and nasal associated lymphoid tissue (NALT).
3.2. Replication of rIBV Beau-R In Vitro Is Sensitive to Temperature
The observation that in vivo replication of Beau-R is essentially restricted to the tissue within
the beak raised an interesting question regarding the potential for temperature to affect replication
and therefore viral dissemination through the host. The continuous movement of air in the upper
respiratory tract will inevitably cool this area of the bird, and it has been demonstrated for several human
respiratory viruses including influenza virus [43,44], Rhinovirus [30,31] and respiratory syncytial
virus (RSV) [45–47] that replication can be confined to the upper respiratory tract as a consequence
of viral replication being sensitive to the comparatively higher temperatures in the lower respiratory
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tract. A growth kinetics assay in CK cells was used to assess whether the replication of Beau-R was
detrimentally affected by an increase in temperature. The core body temperature of a chicken is
considered to be 41 ◦C [48], and therefore this temperature was chosen for all experiments comparing
productive replication to standard conditions using an incubation temperature of 37 ◦C.
Primary CK cells were inoculated with Beau-R or M41-CK and incubated at either 41 ◦C or 37 ◦C,
with supernatant harvested at regular intervals (Figure 2a–d). The titres of infectious Beau-R determined
from cells incubated at 41 ◦C were lower than those from cells incubated at 37 ◦C (p < 0.0001), with very
little viable infectious progeny produced at the higher temperature (Figure 2b). In contrast, the quantity
of infectious progeny released from cells infected with M41-CK was unaffected by temperature at
12 and 24 hpi (Figure 2c). The titres of M41-CK determined from CK cells incubated at 41 ◦C were
observed to be lower at 48 to 96 h (p < 0.0001) than those determined, at similar timepoints, from cells
at 37 ◦C. Although it is clear, from these results, that the replication of both M41-CK and Beau-R is
negatively affected at 41 ◦C, there is a substantial observable difference in the extent to which each
virus is affected. M41-CK is able to sustain a level of replication capable of generating consistent titres
around 104 PFU/mL, whereas Beau-R was unable to sustain any productive infection at the higher
temperature (Figure 2c,d). These results demonstrate that a temperature of 41 ◦C can be considered as
a non-permissive temperature for Beau-R replication.
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To ensure that the temperature sensitive replication phenotype observed for Beau-R was not
specific to the primary CK cells, the replication of both M41-CK and Beau-R was assessed in DF1 cells
(Figure 2e), a continuous cell line derived from chicken embryo fibroblasts [34]. Similar to the results
observed in CK cells, Beau-R replication was negatively affected by incubation at 41 ◦C (p < 0.0001,
Figure 2d), indicating the temperature sensitive replication phenotype for Beau-R was not specific to
cell type. The titres of M41-CK produced at either temperature were below 10 PFU/mL demonstrating
that M41-CK could not initiate productive replication in DF1 cells. This was not unexpected as the
M41-CK spike (S) glycoprotein restricts cell tropism [35]. Whilst it may seem counterintuitive to include
M41-CK in the assay, it was not known whether temperature affected S mediated entry, allowing
viruses to enter cells previously non-permissive to infection.
3.3. Temperature Sensitivity Is Not a Shared Characteristic of Attenuated Strains
The observation that replication of the attenuated strain Beau-R was highly restricted at 41 ◦C
whereas the pathogenic M41-CK strain could both initiate and sustain replication raised the possibility
that temperature sensitivity may be an explanation for attenuation of IBV in vivo. To investigate this
possibility, the replication kinetics at 37 ◦C and 41 ◦C in CK cells of the IBV vaccine strain H120 were
assessed, as were the replication kinetics of the serially passaged M41-CK isolates, M41-CK EP106 A,
M41-CK EP106 A1, M41-CK EP106 C and M41-CK EP106 D [14]. Notably, all these viruses have been
attenuated through serial passage in embryonated hens’ eggs (120 and 106 passages respectively) [12,14],
a process that typically occurs at 37 ◦C. It was hypothesized, therefore, that this process may have
resulted in attenuation of the viruses through selection of a temperature sensitive phenotype causing a
restriction in replication at a higher temperature.
All of the attenuated IBVs investigated were able to initiate and sustain productive replication at
41 ◦C, similar to the phenotype observed for pathogenic M41-CK (Figure 3a–g). The titres produced
from H120 infected cells at 24 hpi were comparable between those cells incubated at 37 ◦C and those at
41 ◦C (Figure 3c). This was also the case for isolates M41-CK EP106 A, M41-CK EP106 A1 and M41-CK
EP106 D (Figure 3d–g). Interestingly, all the viruses investigated exhibited decreased titres of infectious
progeny at 41 ◦C, in comparison to 37 ◦C, at 48 to 96 hpi (p < 0.005), as previously observed for M41-CK.
None of the viruses exhibited the temperature sensitive replication phenotype observed for Beau-R
(Figure 3a). These results showed that attenuation associated with H120 and the multiple passaged
isolates of M41-CK viruses were not due to a restriction in replication linked to temperature sensitivity.
3.4. The Nephropathogenic IBV Strain D388(QX) Is Able to Replicate at 41 ◦C
Although the results described above and in Figure 3 show that temperature sensitivity is not a
shared characteristic of attenuated strains, it also possible that the ability to replicate at 41 ◦C is not
necessarily a trait shared by other pathogenic strains. The observation from our in vivo results that
Beau-R was not detected in tracheal epithelial cells, raised the question of whether attenuation and
resultant viral dissemination was linked to restricted replication resulting from temperature sensitivity
at the core temperature (41 ◦C) of a chicken. It is therefore important to determine whether the ability
of pathogenic M41-CK to grow at 41 ◦C is a trait shared by other pathogenic strains, particularly with
regards to nephropathogenic strains of IBV that disseminate through the bird and infect the kidneys.
The replication kinetics of the nephropathogenic strain D388(QX), a strain associated with severe
infectious bronchitis, resulting from infection in the respiratory tract and also with dissemination
to and resultant pathology in the kidneys and oviducts [36], were assessed at 37 ◦C and 41 ◦C and
compared to M41-CK (Figure 4). Overall, replication of D388(QX) was found to be largely unaffected by
temperature with titres comparable between the two temperatures at 24 and 48 hpi (Figure 4c). Titres
of infectious progeny were lower at 72 and 96 hpi from cells incubated at 41 ◦C, however statistical
significance was only reached for the later time point (p < 0.05). The ability of D388(QX) to establish
and maintain replication at 41 ◦C, like M41-CK, suggests that whilst attenuation and temperature
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sensitivity may not be intrinsically linked, the ability to replicate at higher temperatures may be a
shared characteristic of pathogenic IBV isolates.
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Figure 3. The attenuated strains H120 1-CK EP106 A–D do not share a temperatu e sensitive
replication phenotype co parable to Beau-R. Primary CK cells seeded in 6 well plates were inoculated
with 105 PFU (MOI ~0.01) of (a) Beau-R, (b) M41-CK, (c) H120, (d) M41-CK EP106 A, (e) M41-CK EP106
A1, (f) M41-CK EP106 C or (g) M41-CK EP106 D, and incubated at either 37 ◦C or 41 ◦C. Supernatants
were harvested at 24 h intervals and the quantity of infectious progeny determined via plaque assay
in CK cells. Each point represents the mean of three independent experiments (n = 3) with error
bars representing SEM. Statistical differences were assessed using a two-way ANOVA followed by a
Tukey test for multiple comparisons and are highlighted by * (p < 0.05), ** (p < 0.005), *** (p < 0.0005)
and **** (p < 0.0001).
3.5. Entry at Permissive Temperatures Cannot Recover Replication at Non-Permissive Temperatures
In order to elucidate which step in the IBV replication cycle accounted for the temperature sensitive
replication phenotypes observed, a temperature swap experiment was carried out (Figure 5a). CK cells
were inoculated and incubated at either 37 ◦C or 41 ◦C for 1 h to allow for viral attachment and entry.
The inoculum was removed, and the cells washed to remove unbound virus, the cells were then
either incubated at the same temperature or incubated at the alternative temperature for a further 23 h
(Figure 5a). The resulting supernatants were assessed for infectious viral progeny through titration in
CK cells at 37 ◦C.
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Figure 4. The replication of D388(QX) is unaffected by temperature. Primary CK cells seeded in 12 well
plates were inoculated with 1.5 log10CD50 (MOI ~ 0.001) of M41-CK or D388(QX) and incubated at
41 ◦C or 37 ◦C. Supernatants were harvested at 24 h intervals and the quantity of infectious progeny
determined via plaque assay. Graph (a) represents data generated at 37 ◦C and (b) at 41 ◦C. Graph (c)
represents all data relating to D388(QX) infection and (d) M41-CK. Each point represents the mean
of three independent experiments (n = 3) with error bars representing SEM. Statistical differences
were assessed using a two-way ANOVA followed by a Tukey test for multiple comparisons and are
highlighted b * (p < 0.05), ** ( < 0.005) a d *** (p < 0.0005).
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M41-CK were affected by the swaps in temperature (Figure 5d,e), with Beau-R affected to a greater 
extent than M41-CK. The titres of viral progeny produced were comparable in cells incubated at 37 
°C for binding and entry and then 37 °C for the remainder of the replication cycle (37–37) and those 
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Figure 5. Entry is not the determining factor to whether productive replication is initiated at 41 ◦C. (a)
Schematic detailing experimental protocol. Primary CK cells seeded in 6 well plates were inoculated in
triplicate with 105 PFU of IBV (MOI ~0.01). Cells were incubated for 1 h at ithe 37 ◦C (blue) or 41 ◦C
(red), after which the inoculum was removed and th cells washed to remove unbound vir s. Cells
were incubated at either 37 ◦C or 41 ◦C for 23 h. The quantity of infectious viral progeny produced was
assessed through titration in CK cells. Graph (b) represents data from H120, (c) D388(QX), (d) Beau-R
and (e) M41-CK infection. Each point represents the mean from three independent experiments (n = 3)
with error bars indicating SEM. Statistical differences were assessed using a one-way ANOVA with a
Tukey test for multiple comparisons and are highlighted by ** (p < 0.005) and **** (p < 0.0001).
Viruses 2020, 12, 754 11 of 20
The titres of infectious progeny from CK cells infected with H120 and D388(QX) were unaffected
by a swap in temperature (Figure 5b,c); this was expected as previous results demonstrated that
replication is not affected by temperature at 24 hpi (Figures 3c and 4). The titres of both Beau-R and
M41-CK were affected by the swaps in temperature (Figure 5d,e), with Beau-R affected to a greater
extent than M41-CK. The titres of viral progeny produced were comparable in cells incubated at 37 ◦C
for binding and entry and then 37 ◦C for the remainder of the replication cycle (37–37) and those
incubated at 41 ◦C and then 37 ◦C (41–37), indicating that a difference in the binding and entry step
temperature has no effect on the viral replication step. This indicates that the temperature in which viral
attachment and entry occurred was not the determining factor in establishing a productive infection.
In contrast, titres were significantly lower when cells were incubated at 41–41 in comparison to 41–37,
and also between 37–37 and 37–41 (p < 0.005), demonstrating that a change in the second incubation
temperature affected viral replication. This therefore indicates that the temperature at which the virus
is undergoing active replication, assembly and egress was the determining factor in establishing a
productive infection.
3.6. The Spike Glycoprotein from M41-CK Cannot Rescue Beau-R Replication at 41 ◦C
Coronavirus entry is mediated by the S glycoprotein [49]. In order to exclude viral entry
as the determining factor for the replication of Beau-R at non-permissive temperatures, a rIBV,
BeauR-M41(S), in which the Beaudette S gene was replaced with corresponding gene from M41-CK,
was investigated [35]. Analysis of the growth kinetics at the two temperatures, 37 ◦C and 41 ◦C,
revealed that BeauR-M41(S) displayed comparable growth kinetics to Beau-R at 41 ◦C (Figure 6a).
This result demonstrated that the M41 S glycoprotein could not confer the ability of M41-CK to
replicate at 41 ◦C thus confirming that the IBV receptor binding protein is not responsible for the
restricted growth of Beau-R at 41 ◦C.
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investigated. BeauR-M41-Struct contains Beau-R derived sequence encoding the 5′ UTR and replicase 
gene, with the structural and accessory genes plus the 3′ UTR sequences from M41-CK. Analysis of 
the growth kinetics of BeauR-M41-Struct at the two temperatures revealed that this rIBV, like Beau-
R and BeauR-M41(S), could not establish productive infection at 41 °C (Figure 6b). This result 
demonstrated that the M41-CK derived structural and accessory genes could not confer the ability of 
Figure 6. The structural and accessory genes from M41-CK cannot rescue Beau-R replication at 41 ◦C.
Primary CK cells seeded in 6 well plates were inoculated with (a) 104 PFU (MOI ~0.001) of Beau-R or
BeauR-M41(S) and (b) 105 PFU (MOI ~0.01) of either Beau-R or BeauR-M41-Struct and incubated at
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(n = 3) with error bars representing SEM. Statistical differences were assessed using a two-way ANOVA
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3.7. The Replicase Gene Is a Determinant of Temperature Sensitivity
The results of the temperature swap assays, alongside the inability of BeauR-M41(S) to replicate
at 41 ◦C, indicated that it was not the temperature at which viral entry occurred, but rather the
temperature at which active viral replication took place which determined whether a productive
infection was established. In order to rule out a role for another structural or accessory protein in the
restricted temperature phenotype for Beau-R, a second rIBV, BeauR-M41-Struct [23], was investigated.
BeauR-M41-Struct contains Beau-R derived sequence encoding the 5′ UTR and replicase gene, with the
structural and accessory genes plus the 3′ UTR sequences from M41-CK. Analysis of the growth kinetics
of BeauR-M41-Struct at the two temperatures revealed that this rIBV, like Beau-R and BeauR-M41(S),
could not establish productive infection at 41 ◦C (Figure 6b). This result demonstrated that the M41-CK
derived structural and accessory genes could not confer the ability of M41-CK to replicate at 41 ◦C.
This in turn, indicates that the replicase gene is the determining factor in the temperature sensitivity
associated with the replication of Beau-R.
3.8. Temperature Affects sgRNA Levels during Beau-R Infection
As the IBV replicase gene had been identified as a factor in temperature sensitivity, it was
hypothesised that increasing temperature was negatively affecting the level of RNA synthesis, causing
a reduction in the number of infectious progeny. The coronavirus replicase is responsible both for de
novo synthesis of the full-length genomic RNA thus generating genomic RNA for progeny viruses as
well as generating the replicase proteins, and for the synthesis of a set of subgenomic RNAs (sgRNA),
that are used for the generation of the structural and accessory proteins. In order to investigate
whether the restriction in growth observed for Beau-R at 41 ◦C was linked to RNA expression a series
of infections were used to investigate whether the quantities of sgRNA synthesised differed at the
two different temperatures. Specifically, the levels of the sgRNA responsible for the expression of
nucleocapsid (N) protein was used as an indicator for the level of viral RNA synthesis (Figure 7).
The quantities of infectious viral progeny were determined for a comparison between viral RNA
synthesis and productive virus replication.
At all the time points assessed, M41-CK N sgRNA levels were largely comparable in cells incubated
at 37 ◦C and those incubated at 41 ◦C (Figure 7a), indicating that sgRNA synthesis is not affected
by temperature. Analysis of Beau-R N sgRNA levels showed that the quantity of this sgRNA was
reduced during Beau-R infection, 6 to 24 hpi (p < 0.0005), at 41 ◦C when compared to synthesis at
37 ◦C (Figure 7b). This result implies a reduction in viral RNA synthesis at 41 ◦C, further indicating
the role of the replicase gene for the restriction in growth of Beau-R at 41 ◦C. Interestingly, at the first
time point for analysis, 4 hpi, the quantity of N sgmRNA was higher at 41 ◦C (p < 0.0001); this was
also observed in M41-CK infection but the difference was not statistically significant. The titres of
infectious progeny generated from both M41-CK (Figure 7c) and Beau-R (Figure 7d) infections were
reduced from 10 hpi in cells incubated at 41 ◦C in comparison to 37 ◦C (p < 0.05). The reduction
in Beau-R titres, however, were much more apparent, and alongside the reduction in N sgRNA
levels (Figure 7b), suggests that the reduction in viral titre is likely the result of decreased viral RNA
synthesis. The indication of comparable RNA synthesis for M41-CK at both temperatures (Figure 7a)
does not offer a clear explanation to the moderate drop in viral titre at 41 ◦C, indicating the role of
another factor. Investigation into N protein production (Figure 8) also does not explain the moderate
drop in viral titre. During Beau-R infection at 41 ◦C, at 8, 11 and 24 hpi there was markedly less N
protein detected in comparison to 37 ◦C, which is likely the consequence of reduced N gene sgmRNA
production (Figure 7b). During M41-CK infection there was little difference in the levels of N protein
detected, again indicating that another factor is contributing to the decrease in viral titre. In summary,
the analysis of RNA levels and protein expression with regards to the N gene, suggests that for Beau-R,
RNA synthesis is negatively affected by incubation at 41 ◦C, contributing to reduced protein production
and a decrease in the quantity of infectious progeny virions. For M41-CK, RNA levels and protein
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expression were largely unaffected by temperature, however there was a moderate decrease in viral
titre after 10 hpi at 41 ◦C.
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Figure 8. During Beau-R infection the quantity of N protein is less at 41 ◦C than at 37 ◦C. Primary
CK cells seeded in 6 well plates were inoculated with 106 PFU (MOI ~0.1) Beau-R or M41-CK or
N,N-Bis(2-hydroxyethyl)-2aminoethanesulphonic acid (BES) media for mock infection, and incubated
at either 37 ◦C or 41 ◦C. Cell lysates were harvested at 8, 11, and 24 hpi. Proteins present in the
cell lysates were denatured using SDS lysis buffer and separated on a 4–15% polyacrylamide gel.
The amounts of the IBV N protein present in the samples were analysed by western blot using an
anti-IBV antibody. Levels of actin were analysed using an anti-β-actin as a loadin control. Identified
bands relate to β Actin (43kDa) and the IBV N protein (48kDa).
3.9. Beau-R Replication at 41 ◦C Can Be Rescued by M41-CK
Our results indicate that a component of the IBV replicase protein, playing some role in RNA
synthesis, was responsible for the restricted growth of Beau-R at 41 ◦C. To determine whether this
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was a dominant feature, we decided to assess whether Beau-R replication could restrict replication of
M41-CK, or alternatively whether Beau-R replication could be rescued by M41-CK at 41 ◦C. CK cells
were co-infected with Beau-R and M41-CK and incubated at either 37 ◦C or 41 ◦C. Progeny viruses
in the resultant supernatants were subsequently passaged a further four times in CK cells at the
temperature at which the first stage occurred. The presence of Beau-R and M41-CK genomic material
was detected using an RT-PCR assay targeting the 3′ UTRs [23] (Figure 9). RT-PCR products derived
from Beau-R and M41-CK RNAs, 667 and ~483 nucleotides, respectively, were detected either in
CK cells infected with a single virus, or in cells co-infected with both viruses at 37 ◦C (Figure 9a).
As expected, M41-CK RNA was detected in CK cells incubated at 41 ◦C, whereas Beau-R RNA
was not detected. Both Beau-R and M41-CK derived RNA was detected in CK cells co-infected
with both viruses at 41 ◦C (Figure 9b). These results show Beau-R RNA cannot be detected in CK
cells passaged at 41 ◦C but can be detected in CK cells co-infected with M41-CK, demonstrating
that the M41-CK replicase can rescue the replication of Beau-R genomic RNA at the non-permissive
temperature. This indicates that during coinfection at the non-permissive temperature the M41-CK
replicase is the dominant activity and the Beau-R replicase does not have a negative effect on the
replication of M41-CK. Overall, the results of the co-infection experiments indicates that Beau-R and
M41-CK can infect the same cell at the same time, and that incubation at 41 ◦C does not result in
permanent or non-recoverable damage to the Beau-R RNA, providing further evidence that the Beau-R
replicase is responsible for the observed restriction in replication of Beau-R RNA at 41 ◦C and that the
effect is not due to an impediment with the Beau-R RNA.
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PFU Beau-R and 105 PFU 41- . S media was used for mock infection. Cells were incubated at
(a) 37 ◦C or (b) 41 ◦C, until extensive CPE was observed in the 37 ◦C wells. Progeny virus present in
the supernatants were passaged a further four times in CK cells at the same temperature as the first
passage. RNA was extracted from the final supernatants and assessed for the presence of M41-CK and
Beau-R genomic material by (RT-PCR) analysis using primers targeting the 3′ UTR. RT-PCR products
were separated by agarose gel electrophoresis alongside a 1 KB+ DNA ladder (Invitrogen). The red
arrow highlights the marker bands relating to 1000 and 600 bp. RT-PCR products relating to Beau-R are
~650bp and M41-CK ~450 bp.
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4. Discussion
For birds, as well as mammals, the continuous movement of air through the respiratory tract
results in a temperature gradient in which the upper respiratory tract, including the nasal cavities,
mouth and throat, is cooler than the trachea and lungs that constitute the lower respiratory tract [43].
Research on human pathogens, including influenza virus, rhinovirus and RSV, has indicated that the
temperature of the upper respiratory is between 33–34 ◦C and the lower to be 37 ◦C, commonly denoted
as permissive and non-permissive temperatures, respectively [30–32,50–52]. Unlike humans which
have a core body temperature of 37 ◦C, chickens exhibit a core temperature of 41 ◦C [48], which means
it is likely that the temperature of the upper respiratory tract is 37–38 ◦C, increasing to 41 ◦C in the
lower respiratory tract. The effect of this localised temperature change on the replication of several
respiratory pathogens is well documented and has been linked to viral dissemination through the host,
viral pathogenicity and interspecies transmission [30–32,52–55].
The data presented in this study demonstrates that the attenuated IBV strain, Beau-R, exhibits
a temperature sensitive replication phenotype and is unable to replicate productively at 41 ◦C.
This temperature sensitivity may account for the attenuated phenotype observed during in vivo
infection (Figure 1), as it will inevitably contribute to the inability of Beau-R to disseminate from the
point of inoculation to the lower respiratory tract. Infectious Beau-R was only detected in harvested
beak tissue (Table 1) and was not detected in the trachea or the eyelid, unlike M41-CK that was
shown to replicate in these sites and was shown to replicate successfully at 41 ◦C. Unlike Beau-R,
the replication of other attenuated IBV isolates, including the vaccine H120, were found not to be
temperature sensitive (Figure 3), indicating that temperature sensitivity may not be a universal cause
of attenuation or loss of virulence. More importantly, however, another pathogenic isolate of IBV
investigated that can also replicate in primary CK cells, D388(QX) was, in addition to M41-CK, able to
replicate at 41 ◦C (Figure 4). This may suggest that the ability to replicate at higher temperature may
be a shared characteristic of pathogenic isolates of IBV, and in particular nephropathogenic strains
that have to disseminate deep into the body of the bird, to infect the kidneys, oviducts and enteric
tract. This latter point is of particular interest as the replication kinetics of D388(QX) were found to
be comparable at 37 ◦C and 41 ◦C (Figure 6) whereas M41-CK, a classical respiratory strain, was able
to replicate at 41 ◦C but did experience a moderate reduction in viral titre at the higher temperature.
This may, in part, explain why M41 is less often detected in the kidney during in vivo infection.
To conclusively state that the ability to replicate at higher temperatures is a shared characteristic of
pathogenic isolates further investigation of more IBV strains, which is difficult as many IBV pathogenic
field strains cannot be propagated in vitro, will be required.
Temperature sensitivity is not a novel topic in the field of virology and has been widely studied
for RNA viruses since the mid-1900s [43,56,57]. The analysis of temperature sensitive mutants has
been used to identify genes involved in viral replication and pathogenesis as well as aiding in the
generation of vaccine viruses [29,46,47,55,58–63]. Whilst temperature sensitivity has not been a popular
research subject for IBV, [64–66], several temperature sensitive mutants of the Betacoronavirus mouse
hepatitis virus (MHV) have been generated [55,62,67]. These mutants all carry mutations within
the replicase gene, supporting the data presented in this study that the Beau-R replicase gene is a
determinant of temperature sensitivity (Figure 6). These mutants also have defects in viral RNA
synthesis [62]. The analysis of N protein sgRNA levels indicates that Beau-R also experiences defects
in RNA synthesis at higher temperatures (Figure 7) but further research is required to elucidate both
the extent of these defects and the mechanism behind them. The cause of the moderate reduction in
M41-CK titres observed at 41 ◦C also requires further investigation as the data described here indicates
that this is not the result of disrupted RNA synthesis (Figure 7). It is possible that protein–protein
interactions, processing of the polyprotein, proteolytic cleavage or protein stability and/or activity are
affected [55,67–69] or even that the virus-host response has been altered [31,55,67]. Interestingly a recent
publication examining the effect of temperature on the replication on both SARS-CoV and SARS-CoV-2
has highlighted a temperature dependent type I interferon mediated antiviral response [70].
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Regardless of the cause of Beau-R temperature sensitivity, the identification of a temperature
sensitive replication phenotype, alongside restricted replication in vivo, may have implications for
the further development of Beau-R as a vaccine vector. It is well established that the Beaudette strain
replicates poorly in vivo, with the molecular clone Beau-R behaving comparably [15]. Additionally,
vaccination of birds with Beau-R does not induce a protective immune response against M41-CK
challenge [15]. Although vaccination with Beau-R expressing heterologous S genes can induce a partial
protective immune response against homologous challenge, it does not meet the standards set by the
European Pharmacopoeia, with one hypothesis reasoning that this is the result of poor levels of in vivo
replication [15,16,20].
Beau-R is, however, a powerful molecular tool for coronavirus research. The temperature sensitive
mutants identified for MHV have proved extremely useful in elucidating the specific roles of individual
replicase proteins (nsps) as well as protein-protein and protein-RNA interactions during the coronavirus
replication cycle [55,62,67,71]. Furthermore, temperature sensitive mutants have identified pathogenic
determinants within the MHV genome and have also been demonstrated to protect mice against
lethal challenge [55,67]. Temperature sensitivity has been used in development of vaccines against
RSV [46] and influenza virus [32,61]. It is therefore possible, with further research into temperature
sensitive lesions within the Beau-R replicase gene, that temperature sensitivity could be used to achieve
attenuation of other IBV strains for future vaccine development, as well as a research tool to investigate
the functions of the IBV replicase proteins.
5. Conclusions
The Gammacoronavirus IBV is a highly contagious economically important respiratory pathogen of
domestic fowl. Current live attenuated vaccines are generated through serial passage of a virulent isolate
through embryonated hens’ eggs; the molecular mechanism is unknown. The research described here
identifies that the replication of the attenuated IBV strain Beau-R is temperature sensitive and is highly
restricted in chickens to the soft tissue within the beak. The temperature sensitive replication phenotype
of Beau-R was found to be associated with the replicase gene and with defects in sub-genomic mRNA
synthesis. These findings highlight the possibility of utilising temperature sensitivity as a method for
rational attenuation and vaccine development as seen with pathogens such as influenza virus.
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